Effects of intensive insulin therapy upon pancreatic β cell function in patients newly diagnosed with type II diabetes

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 1, 2015, Pages 1391-

  Wang, Defeng ^a   Sun, Li ^a   Song, Guangyao ^b   Chen, Shuchun ^b  

^a HEBEI UNIVERSITY OF ENGINEERING   (China)

^b HEBEI GENERAL HOSPITAL   (China)

Author keywords

Diabetes; Insulin; Noninsulin dependent; Pancreatic cell

Indexed keywords

C PEPTIDE; GLICLAZIDE; GLYCOSYLATED HEMOGLOBIN; ISOPHANE INSULIN; METFORMIN; PIOGLITAZONE; RECOMBINANT HUMAN INSULIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; ASSESSMENT OF HUMANS; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG EFFICACY; FASTING GLUCOSE BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN RESISTANCE; INSULIN RESISTANCE INDEX; INSULIN SECRETION INDEX; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL;

EID: 84923066168     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Charles MA, Bennett PH. A two-step model for development of non-insulindependent diabetes. Am J Med 1991; 90: 229-235.
2. Robertson RP, Harmon J, Tran PO, Poitout V. Beta-Cell glucotoxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 2004; 53: S119-S124.
3. Yki-Jarvinen H. Glucose toxicity. Endocr Rev 1992; 13: 415-431.
4. Samanta A, Burden AC, Jones GR, Clarkson L. The effect of short-term intensive insulin therapy in non-insulin-dependent diabetes who had failed on sulphonylurea therapy. Diabetes Res 1986; 3: 269-271.
5. Yki-Jarvinen H, Esko N, Eero H, Taskmo MR. Clinical benefits and mechanisms of sustained response to intermittent insulin therapy in type 2 diabetic patients with secondary drug failure. Am J Med 1988; 84: 185-192.
6. Li Y, Xu W, Liao Z, Yao B, Huang Z, Weng J. The effect of continuous subcutaneous insulin infusion (CSII) on glucose metabolism and induction of long-term glycemic control in newly diagnosed type 2 diabetic patients (Abstract). Diabetes 2004; 53: A112.
7. Weng J, Li Y, Xu W, Chen X, Liao Z, Yao B, Deng W, Ou X, Hu G. The effect of short-term continuous subcutaneous insulin infusion treatment on beta-cell function in newly diagnosed type 2 diabetic patients. Chinese Journal of Diabetes 2003; 11: 10-15.
8. Zhu F, Ji L, Han X, Zhu Y, Zhang H, Zhou X, Chen J, Cai X, Zhang M. Induction of long-tern glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Chinese Journal of Diabetes 2003; 11: 5-9.
9. Gorden P, Hendricks CM, Roth J. Circulating proinsulin-like component in man: increased proportion in hypoinsulinemia state. Diabeto-logia 1974; 10: 469-474.
10. Brunzell JD, Robertson RP, Lerner RL, Hazzard WR, Ensinck JW, Bierman EL, Porte D Jr. Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab 1976; 42: 222-229.
11. Weyer C, Tataranni PA, Bogardus C, Pratley RE. Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care 2001; 24: 89-94.
12. Leahy JL, Bonner-Weir S, Weir GC. Beta-cell dysfunction induced by chronic hyperglycemia: current ideas on mechanism of impaired glucose-induced insulin secretion. Diabetes Care 1992; 15: 442-455.
13. Gleason CE, Gonzalez M, Harmon JS, Robertson RP. Determinants of glucotoxicity and its reversibility in the pancreatic islet beta-cell line, HIT-T15. Am J Physiol Endocrinol Metab 2000; 279: E997-E1002.
14. McFarlane SI, Chaiken RL, Hirsch S, Harrington P, Lebovitz HE, Banerji MA. Near-normoglyca-emic remission in African-Americans with type 2 diabetes mellitus is associated with recovery of beta cell function. Diabet Med 2001; 18: 10-16.
15. Byrne MM, Sturis J, Sobel RJ, Polonsky KS. Elevated plasma glucose 2 h postchallenge predicts defects in beta-cell function. Am J Physiol 1996; 270: E572-E579.
16. Ryan EA, Imes S, Liu D, McManus R, Finegood DT, Polonsky KS, Sturis J. Defects in insulin secretion and action in women with a history of gestational diabetes. Diabetes 1995; 44: 506-512.
17. Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus. JAMA 1999; 281: 2005-2012.
18. Della Casa L, del Rio G, Glaser B, Cerasi E. Effect of 6-month gliclazide treatment on insulin release and sensitivity to endogenous insulin in NIDDM. role of initial continuous subcutaneous insulin infusion induced normoglycemia. Am J Med 1991; 90: 37S-45S.